Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HairClone has launched the world’s first licensed follicle banking service, allowing patients to store their own follicles for future use. The company’s primary therapeutic approach—multiplying a patient’s own dermal papilla cells and injecting them back into the scalp—is entering pre-clinical optimization/testing in 2025 before moving into formal clinical trials. No published human efficacy data yet; initial focus on safety and process optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HairClone.